BAGGIO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.013
EU - Europa 1.063
AS - Asia 514
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
SA - Sud America 2
Totale 10.601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.008
CN - Cina 404
FI - Finlandia 244
UA - Ucraina 244
DE - Germania 225
SE - Svezia 183
VN - Vietnam 95
GB - Regno Unito 76
IT - Italia 59
IE - Irlanda 20
IN - India 11
EU - Europa 5
AU - Australia 4
CA - Canada 4
FR - Francia 4
NL - Olanda 4
RS - Serbia 2
BR - Brasile 1
ES - Italia 1
KH - Cambogia 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SG - Singapore 1
TR - Turchia 1
Totale 10.601
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.362
Fairfield 1.036
Jacksonville 913
Ann Arbor 907
Houston 861
Chandler 742
Ashburn 522
Wilmington 426
Princeton 358
Cambridge 351
Seattle 349
San Diego 100
Beijing 97
Nanjing 96
Des Moines 95
Dong Ket 94
Roxbury 89
Boardman 85
Medford 72
Helsinki 67
Hebei 37
Guangzhou 34
Norwalk 31
Nanchang 29
Jiaxing 24
Shenyang 21
Dublin 20
Redwood City 15
Changsha 13
New York 12
Kharkiv 11
Tianjin 10
Jinan 9
London 8
Washington 8
Detroit 7
Borås 6
Greifswald 6
Los Angeles 5
Ogden 5
Bologna 4
Tappahannock 4
Auburn Hills 3
Costa Mesa 3
Indiana 3
Kilburn 3
Lanzhou 3
Milan 3
Padova 3
Rockville 3
Rome 3
Zhengzhou 3
Chengdu 2
Chicago 2
Chiswick 2
Delhi 2
Falls Church 2
Hefei 2
Islington 2
Kunming 2
Nürnberg 2
Orbassano 2
Redmond 2
San Jose 2
Selargius 2
Shanghai 2
Sydney 2
Toronto 2
Viterbo 2
Wuhan 2
Acqui Terme 1
Acton 1
Atlanta 1
Belgrade 1
Camisano Vicentino 1
Camposampiero 1
Caserta 1
Catford 1
Chongqing 1
Coquitlam 1
Davao City 1
Eindhoven 1
Fazenda Rio Grande 1
Florence 1
Frankfurt am Main 1
Genova 1
Girifalco 1
Greenwich 1
Groningen 1
Haikou 1
Hangzhou 1
Hanoi 1
Henderson 1
Horia 1
Hounslow 1
Kiel 1
Lachine 1
Leawood 1
Lima 1
Monmouth Junction 1
Totale 9.037
Salva come PNG Salva come JPEG
Nome #
DIFFERENT HEPARIN DOSAGES ARE NEEDED TO AMELIORATE THE EVOLUTION OF DIFFERENT EXPERIMENTAL NEPHROPATHIES - DOES THIS MEAN DIFFERENT HEPARIN TARGETS 129
Tyrosine-protein kinase inhibition in human erythrocytes by polyphosphoinositides (PIP and PIP2) 119
Functional correlation between the Ser/Thr-phosphorylation of band-3 and band-3-mediated transmembrane anion transport in human erythrocytes 118
VERY EARLY NUTRITION SUPPLEMENTATION IN BURNED PATIENTS 117
An inheritable anomaly in red-cell oxalate transport in ''primary'' calcium nephrolithiasis correctable with diuretics. 114
THERAPY WITH GLYCOSAMINOGLYCANS IN NEPHROLOGY 114
In vivo activation of renal phospholipase activity by bradykinin in the rat. 114
Abnormal erythrocyte charge in diabetes mellitus: link with microalbuminuria. 112
A critical evaluation of the urinary inhibiting activity in idiopathic calcium oxalate nephrolithiasis. 111
Relationship Between Membrane-protein Phosphorylation and Intracellular Translocation of Casein Kinase In Human Erythrocytes 110
DIALYSIS-RELATED AMYLOIDOSIS 109
Pathogenesis of idiopathic calcium nephrolithiasis: Update 1997 108
Acquisizione del fenotipo miofibroblastico e transizione epItelio mesenchima in colture primarie di cellule renali umane. 105
Further insights about the beneficial effects of n-3 fatty acids in the early molecular events of renal fibrosis in vitro. 104
Patterns of renal injury in NIDDM patients with microalbuminuria 101
ABNORMAL URATE TRANSPORT IN ERYTHROCYTES OF PATIENTS WITH IDIOPATHIC CALCIUM NEPHROLITHIASIS - A POSSIBLE LINK WITH HYPERURICOSURIA 101
Digitalis and the renin-angiotensin axis in congestive heart failure. 100
Genetic approach to the study of cellular ion transport anomalies in idiopathic calcium nephrolithiasis 99
ACE INHIBITORS IN RENAL-DISEASE 99
Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid 99
Arachidonic acid-induced IL-6 expression is mediated by PKCalpha activation in osteoblastic cells 99
Renal impairment and moderate alcohol consumption in the elderly. Results from the Italian Longitudinal Study on Aging (ILSA). 99
EFFECTS OF THE ORAL-ADMINISTRATION OF GLYCOSAMINOGLYCANS ON CELLULAR ABNORMALITIES ASSOCIATED WITH IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS 97
EFFECT OF ALKALINE CITRATE THERAPY ON CLEARANCE OF RESIDUAL RENAL STONE FRAGMENTS AFTER EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY IN STERILE CALCIUM AND INFECTION NEPHROLITHIASIS PATIENTS 97
An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics. 96
GLYCOSAMINOGLYCAN CONTENT, OXALATE SELF-EXCHANGE AND PROTEIN-PHOSPHORYLATION IN ERYTHROCYTES OF PATIENTS WITH IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS 95
ANTIPROTEINURIC EFFECT OF GLYCOSAMINOGLYCANS 94
Ischemic renal disease: impact of cardiovascular risk factors and smoking 93
DIET AND NEPHROLITHIASIS - STUDY IN AN OBESE POPULATION 91
CORRECTION OF ERYTHROCYTE ABNORMALITIES IN IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS AND REDUCTION OF URINARY OXALATE BY ORAL GLYCOSAMINOGLYCANS 90
Abnormal urate transport in erythrocytes of idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria. 90
Relation between band 3 red blood cell protein and transmembrane oxalate flux in stone formers. 90
Phosphorylation of Band-3 Protein In Nephrolithiasis 89
Glycosaminoglycans: A new paradigm in the prevention of proteinuria and progression of glomerular disease 88
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 87
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. 87
Kidney kallikrein and phospholipase activities in Milan spontaneously hypertensive rats. 85
Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis 85
Urinary angiotensin-I-converting enzyme activity as a marker of tubulo-interstitial involvement in kidney diseases. 84
Mesangial cell proliferation in long-term streptozotocin-induced diabetes mellitus in the rat and the renoprotective activity of heparin 83
Cardiovascular risk factors, smoking and kidney function 82
Protein diet and hypercalciuria 82
ROLE OF GLYCOSAMINOGLYCANS IN DIABETIC NEPHROPATHY 82
EFFECT OF HEPARIN TREATMENT ON GLOMERULAR COLLAGEN-IV-ALPHA-1 AND TGF-BETA-1 EXPRESSION AND DEPOSITION IN DIABETIC RATS 81
Renal structure incaucasian noninsulindependent diabetic patients. 81
ERYTHROCYTE URATE SELF EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 81
Abnormal arachidonic acid content of membrane phospholipids - the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis 80
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes 80
Arachidonic acid and its metabolites prostaglandin 1 and 2 increase intracellular calcium in cultured human osteoblast-like MG63 cells. 79
Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP-2/TIMP-2 mRNA expression 79
Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. 78
Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis. 78
A comparative kinetic RT/-PCR strategy for the quantitation of mRNAs in microdissected human renal biopsy specimens 76
Isolation and properties of a protein kinase from rat liver microsomes. 75
MOLECULAR PATHOGENESIS OF MEMBRANOUS NEPHROPATHY 74
Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis. 73
Von Willebrand factor abnormalities in IgA nephropathy. 73
ERYTHROCYTE URATE SELF-EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 73
Use of glycosaminoglycans to increase efficiency long-term continuous peritoneal dialysis. 73
Vascular endothelial growth factor expression in microdissected glomeruli of type 2 diabetic patients. 72
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 72
Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. 72
ERYTHROCYTE URATE SELF-EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 72
Treatment with glycosaminoglycans of renal diseases related problems. 71
Erythrocyte membrane protein phosphorylation in urolithiasis. 71
Patterns of renal injury in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. 71
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients 70
Growth factors and the kidney in diabetes mellitus. 70
Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis 69
Mechanism of oxalate cellular transport in idiopathic calcium nephrolithiasis 68
Calcium nephrolithiasis - A systemic disease 67
EFFECT OF HEPARIN TREATMENT ON GLOMERULAR-ALPHA-1-(IV)-COLLAGEN AND TGF-BETA-1 EXPRESSION AND DEPOSITION IN DIABETIC RATS 67
Renal function in the elderly: is the decline inevitable? 66
Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. 66
Molecular biology of diabetic glomerulosclerosis 66
Genetic and dietary factors in idiopathic calcium nephrolithiasis. What do we have what do we need? 65
TGF-beta 1 renal overexpression in diabetic rats and in high glucose mesangial cell cultures: Inhibition by heparinoids. 64
Ultrastructural measures of glomerular extracellular matrix accumulation in non-proteinuric type 2 diabetic patients. 63
IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS - A CELLULAR-DISEASE 63
Experimental peritoneal fibrosis: Favorable effects of glycosaminoglycans (GAGS) 62
Diagnostic and therapeutic approach in patients with urinary calculi 62
High urinary excretion of glycosaminoglycans: a possible marker of glomeular involvement in diabetes. 61
Oral glycosaminoglycans (GAGs) ameliorate peritoneal transport in CAPD patients. 61
Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis 60
Specific modulatory effect of arachidonic acid on bone cytokine mRNA expression 58
Altered Red-blood-cell Membrane-protein Phosphorylation In Idiopathic Calcium-oxalate Nephrolithiasis 58
Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinoger and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA) 56
Renal impairment in chronic cigarette smokers. 56
Fatty acids and idiopathic calcium nephrolithiasis 56
Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalte nephrolithiasis. 56
Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels and the urinary excretion of calcium and oxalate in the rat: insorgence of calcium lithogenesis 56
Nutrition and calcium nephrolithiasis: The lipid hypothesis 55
Evidence of a link between erythrocyte band 3 phosphorylation and anion transport in patients with 'idiopathic' calcium oxalate nephrolithiasis. 55
Arachidonic acid influences intracellular calcium handling in human osteoblasts 54
Cigarette smoking and renal function impairment - Reply 53
EPA and DHA suppress AngII- and arachidonic acid-induced expression of profibrotic genes in human mesangial cells. 53
IS HYPERPROSTAGLANDINURIA A PRIMITIVE PHENOMENON IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 52
ANOMALOUS ARACHIDONIC-ACID METABOLISM IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 52
Glicosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats 51
Intracellular processing of transforming growth factor-beta in mesangial cells 51
Totale 8.025
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.033
article - articoli 28.127
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 114
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.699
Totale 61.973
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019502 0 0 0 0 0 0 0 0 0 0 284 218
2019/20201.850 336 41 29 139 167 183 139 229 154 211 101 121
2020/20211.435 36 149 19 125 51 186 36 134 255 80 205 159
2021/20221.639 20 255 90 162 112 85 22 168 114 24 193 394
2022/20231.567 364 141 10 167 314 246 1 89 154 6 52 23
2023/2024453 26 82 64 48 34 40 21 123 12 3 0 0
Totale 10.630